Evidence map›Paper›PMID 34436295›Full record

ArticleMarine drugs2021

Ameliorative Effects of Peptides Derived from Oyster (

Xing-Wei Xiang, Hui-Zhen Zheng, Rui Wang, Hui Chen, Jin-Xing Xiao, Bin Zheng, Shu-Lai Liu, Yu-Ting Ding

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Combined Effects of Diosmin, Hesperidin,International journal of molecular sciences · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Immunomodulatory effects ofFrontiers in immunology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xing-Wei XiangCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Hui-Zhen ZhengCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Rui WangCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Hui ChenCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Jin-Xing XiaoOcean Research Center of Zhoushan, Zhejiang University, Zhoushan 316000, China.
Bin ZhengFood and Pharmacy College, Zhejiang Ocean University, Zhoushan 316000, China.
Shu-Lai LiuCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.ORCID 0000-0002-6416-5897
Yu-Ting DingCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou 310014, China.
Zhejiang Marine Fisheries Research Institute · CNZhejiang Ocean University · CN

Funding

National Key Research and Development Program of China 2020YFD0900902
6 · The paper itself

Abstract

The intestinal flora is recognized as a significant contributor to the immune system. In this research, the protective effects of oyster peptides on immune regulation and intestinal microbiota were investigated in mice treated with cyclophosphamide. The results showed that oyster peptides restored the indexes of thymus, spleen and liver, stimulated cytokines secretion and promoted the relative mRNA levels of Th1/Th2 cytokines (IL-2, IFN-γ, IL-4 and IL-10). The mRNA levels of Occludin, Claudin-1, ZO-1, and Mucin-2 were up-regulated, and the NF-κB signaling pathway was also activated after oyster peptides administration. Furthermore, oyster peptides treatment reduced the proportion of

Indexed as

OstreidaeAnimalsAquatic OrganismsCyclophosphamideCytokinesDisease Models, AnimalGastroenteritisGastrointestinal MicrobiomeImmunologic FactorsImmunomodulationImmunosuppressive AgentsMaleMiceMice, Inbred BALB CPeptidesPhytotherapyCyclophosphamideCytokinesImmunologic FactorsImmunosuppressive AgentsPeptidescyclophosphamidegut microbiotaimmunomodulatoryoyster (Crassostrea gigas)peptidesshort-chain fatty acid

Identifiers

PMID34436295
PMCPMC8401037
OpenAlexW3188139486

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.